Interestingly, among all, only the active SREBP2 level was found to be upregulated in NPY-treated control cells, in contrast to untreated or Y5rKO cancer cells as well as in NPY-treated parental lung cancer cells (Fig. 4D-E). The gene discussed is NPY; the disease is lung carcinoma.